Gufic Biosciences jumps on the bourses
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Gufic Biosciences is currently trading at Rs. 227.70, up by 5.05 points or 2.27% from its previous closing of Rs. 222.65 on the BSE.
The scrip opened at Rs. 228.90 and has touched a high and low of Rs. 234.00 and Rs. 225.75 respectively. So far 7609 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 289.55 on 21-Apr-2022 and a 52 week low of Rs. 170.20 on 29-Nov-2021.
Last one week high and low of the scrip stood at Rs. 234.00 and Rs. 217.90 respectively. The current market cap of the company is Rs. 2207.43 crore.
The promoters holding in the company stood at 75.48%, while Institutions and Non-Institutions held 2.63% and 21.89% respectively.
Gufic Biosciences has targeted to capture major share of Rs 3000 crore lyophilized antibacterial market in India. Gufic has launched New Drug Delivery System: Dual Chamber Bags at affordable price for the first time in India.
Contributing immensely to the government's ambitious Make in India drive, Gufic has collaborated with its European counterpart to manufacture this new technology indigenously in India. Until now the dual chamber bags have been largely imported in India at a very high cost to the patients. On the contrary, Gufic has not only launched high-quality Dual Chamber Bags at an affordable and pocket friendly price, these New Drug Delivery System products even have longer shelf -life.
Gufic Biosciences is engaged in diversified business viz. Pharma, Healthcare, Bio- Technology, Seeds, Herbal etc.
